enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Liraglutide - Wikipedia

   en.wikipedia.org/wiki/Liraglutide

   Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. [6] [7] It is a second-line therapy for diabetes following first-line therapy with metformin. [6] [8] Its effects on long-term health outcomes like heart disease and life expectancy are unclear.

3. Here's why researchers think most people stop taking weight ...

   www.aol.com/finance/heres-why-researchers-think...

   Nearly 2 in 3 people who sought to lose weight quit popular weight loss and diabetes drugs such as Ozempic or Victoza within one year, according to a new study.. About 65% of those without ...

4. Victoza: Generic GLP-1 Drug Similar to Ozempic Now Available

   www.aol.com/lifestyle/victoza-generic-glp-1-drug...

   A new generic of the GLP-1 drug Victoza, which is similar to popular medications like Ozempic, Wegovy, Mounjaro, and Zepbound, is now available in the United States.

5. Nephrotoxicity - Wikipedia

   en.wikipedia.org/wiki/Nephrotoxicity

   Nephrotoxicity is toxicity in the kidneys. It is a poisonous effect of some substances, both toxic chemicals and medications, on kidney function. [1] There are various forms, [2] and some drugs may affect kidney function in more than one way. Nephrotoxins are substances displaying nephrotoxicity.

6. Teva launches generic version of Novo Nordisk's diabetes drug ...

   www.aol.com/news/teva-launches-generic-version...

   Victoza, chemically known as liraglutide, is a once-daily injection approved for use in adults and children aged 10 or older with type 2 diabetes. Teva launches generic version of Novo Nordisk's ...

7. Novo Nordisk - Wikipedia

   en.wikipedia.org/wiki/Novo_Nordisk

   The i3-diabetes programme is a collaboration between the King's Health Partners, one of only six Academic Health Sciences Centres (AHSCs) in England, and Novo Nordisk. The programme is a five-year collaboration designed to deliver personalised care that will lead to improved outcomes for people living with diabetes, and more efficient and ...

8. America’s Most Admired Lawbreaker - The Huffington Post

   highline.huffingtonpost.com/miracleindustry/...

   In 1999, Johnson & Johnson had signed a contract with a company called Excerpta Medica. Its specialty was medical marketing. Its sub-specialty was producing ghostwritten, data-filled studies on the efficacy and safety of a client’s drugs, finding the right academic scholars to be listed as the authors and then placing the articles in prestigious academic journals.

9. Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients - AOL

   www.aol.com/news/novo-nordisks-victoza-gets-fda...

   Novo Nordisk's (NVO) Victoza gets FDA approval for the treatment of pediatric patients aged 10 years or older with type II diabetes.